Medivie Therapeutic Ltd (MDVI) — Working Capital to Net Assets Ratio
Medivie Therapeutic Ltd (MDVI) has a Working Capital to Net Assets ratio of 126.6% as of June 2021. Working capital of ILA-5.64 Million (current assets of ILA3.22 Million minus current liabilities of ILA8.86 Million) is measured against net assets of ILA-4.46 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Medivie Therapeutic Ltd (MDVI) financial flexibility to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Medivie Therapeutic Ltd Working Capital to Net Assets (2010–2020)
This chart shows how Medivie Therapeutic Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2010 to 2020. As of June 2021, the ratio stands at 126.6%, reflecting working capital of ILA-5.64 Million against net assets of ILA-4.46 Million ILA. See defensive interval ratio of Medivie Therapeutic Ltd to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Medivie Therapeutic Ltd (2010–2020)
The table below presents the year-by-year Working Capital to Net Assets ratio for Medivie Therapeutic Ltd from 2010 to 2020, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see MDVI company net worth.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | -74.0% | ILA-2.76 Million | ILA3.73 Million | ILA5.07 Million | ILA7.82 Million | ▼ -111.3 pp |
| 2019 | 37.3% | ILA2.19 Million | ILA5.88 Million | ILA8.72 Million | ILA6.53 Million | ▼ -22.6 pp |
| 2018 | 59.9% | ILA7.29 Million | ILA12.18 Million | ILA11.61 Million | ILA4.32 Million | ▲ +33.6 pp |
| 2017 | 26.3% | ILA4.27 Million | ILA16.26 Million | ILA7.72 Million | ILA3.45 Million | ▼ -67.2 pp |
| 2016 | 93.4% | ILA539.00K | ILA577.00K | ILA2.34 Million | ILA1.80 Million | ▼ -26.5 pp |
| 2015 | 119.9% | ILA-632.00K | ILA-527.00K | ILA473.00K | ILA1.10 Million | ▲ +20.4 pp |
| 2014 | 99.5% | ILA2.25 Million | ILA2.26 Million | ILA3.87 Million | ILA1.62 Million | ▼ -2.6 pp |
| 2013 | 102.1% | ILA-1.55 Million | ILA-1.52 Million | ILA495.00K | ILA2.05 Million | ▲ +38.8 pp |
| 2012 | 63.3% | ILA773.00K | ILA1.22 Million | ILA2.13 Million | ILA1.36 Million | ▼ -206.1 pp |
| 2011 | 269.4% | ILA9.84 Million | ILA3.65 Million | ILA12.33 Million | ILA2.48 Million | ▲ +260.8 pp |
| 2010 | 8.6% | ILA-488.00K | ILA-5.68 Million | ILA2.93 Million | ILA3.42 Million | — |